Acrivastine

未找到该活性成分的已注册品牌。

该活性成分暂无已收录的食物注意事项。

• Etrasimod重大

  当 Etrasimod 与 Acrivastine 联合使用时，发生 QTc 间期延长 ve 尖端扭转型室性心动过速 的风险或严重程度可能增加。

  专业视图

  The risk or severity of QTc prolongation and torsade de pointes can be increased when Etrasimod is combined with Acrivastine.

• 2,5-Dimethoxy-4-ethylamphetamine中等

  2,5-Dimethoxy-4-ethylamphetamine 可能减弱 Acrivastine 的镇静作用。

  专业视图

  2,5-Dimethoxy-4-ethylamphetamine may decrease the sedative activities of Acrivastine.

• 4-Bromo-2,5-dimethoxyamphetamine中等

  4-Bromo-2,5-dimethoxyamphetamine 可能减弱 Acrivastine 的镇静作用。

  专业视图

  4-Bromo-2,5-dimethoxyamphetamine may decrease the sedative activities of Acrivastine.

• Abacavir中等

  Abacavir 可能减慢 Acrivastine 的排泄速度，从而可能导致血药浓度升高。

  专业视图

  Abacavir may decrease the excretion rate of Acrivastine which could result in a higher serum level.

• Aceclofenac中等

  Aceclofenac 可能减慢 Acrivastine 的排泄速度，从而可能导致血药浓度升高。

  专业视图

  Aceclofenac may decrease the excretion rate of Acrivastine which could result in a higher serum level.

• Aceprometazine中等

  当 Acrivastine 与 Aceprometazine 联合使用时，发生 QTc 间期延长 的风险或严重程度可能增加。

  专业视图

  The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Aceprometazine.

• Acetaminophen中等

  Acetaminophen 可能减慢 Acrivastine 的排泄速度，从而可能导致血药浓度升高。

  专业视图

  Acetaminophen may decrease the excretion rate of Acrivastine which could result in a higher serum level.

• Acetazolamide中等

  Acetazolamide 可能加快 Acrivastine 的排泄速度，从而可能导致血药浓度降低并使疗效降低。

  专业视图

  Acetazolamide may increase the excretion rate of Acrivastine which could result in a lower serum level and potentially a reduction in efficacy.

• Acetylsalicylic acid中等

  Acetylsalicylic acid 可能减慢 Acrivastine 的排泄速度，从而可能导致血药浓度升高。

  专业视图

  Acetylsalicylic acid may decrease the excretion rate of Acrivastine which could result in a higher serum level.

• Aclidinium中等

  Aclidinium 可能减慢 Acrivastine 的排泄速度，从而可能导致血药浓度升高。

  专业视图

  Aclidinium may decrease the excretion rate of Acrivastine which could result in a higher serum level.